Evidence map›Paper›PMID 19228195›Full record

ReviewThe FEBS journal2009

Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.

James J Champoux, Sharon J Schultz

Open access · bronzeAbstract readReview
In one paragraph

Review in The FEBS journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 74 citations in OpenAlex.

  1. Ribonucleotide errors, RNase HII, and ribonucleotide excision repair.Critical reviews in biochemistry and molecular biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. M-MuLV reverse transcriptase: Selected properties and improved mutants.Computational and structural biotechnology journal · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James J ChampouxDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA. champoux@u.washington.edu
Sharon J Schultz
University of Washington · US

Funding

The Enzymology of M-MuLV and HIV ReplicationR01CA051605 · NCI · UNIVERSITY OF WASHINGTON · PI CHAMPOUX, JAMES J · 1989 to 2009
$2.8M
ENZYMOLOGY OF M-MULV AND HIV REPLICATIONR37CA051605 · NCI · UNIVERSITY OF WASHINGTON · PI CHAMPOUX, JAMES J · 1995 to 1999
–
NCI NIH HHS CA51605NCI NIH HHS R01 CA051605NCI NIH HHS R37 CA051605
6 · The paper itself

Abstract

Retroviral reverse transcriptases possess both a DNA polymerase and an RNase H activity. The linkage with the DNA polymerase activity endows the retroviral RNases H with unique properties not found in the cellular counterparts. In addition to the typical endonuclease activity on a DNA/RNA hybrid, cleavage by the retroviral enzymes is also directed by both DNA 3' recessed and RNA 5' recessed ends, and by certain nucleotide sequence preferences in the vicinity of the cleavage site. This spectrum of specificities enables retroviral RNases H to carry out a series of cleavage reactions during reverse transcription that degrade the viral RNA genome after minus-strand synthesis, precisely generate the primer for the initiation of plus strands, facilitate the initiation of plus-strand synthesis and remove both plus- and minus-strand primers after they have been extended.

Indexed as

Transcription, GeneticBiocatalysisModels, MolecularProtein ConformationRetroviridaeRibonuclease HStructure-Activity RelationshipSubstrate SpecificityRibonuclease H

Identifiers

PMID19228195
PMCPMC2742777
OpenAlexW1610099020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.